Monday, October 3, 2016

hydroxyurea



hye-drox-ee-ure-EE-a


Oral route(Capsule)

Treatment of patients with hydroxyurea may be complicated by severe, sometimes life-threatening, adverse effects. Hydroxyurea is mutagenic and clastogenic, and causes cellular transformation to a tumorigenic phenotype which implies a carcinogenic risk to humans. In patients receiving long-term hydroxyurea for myeloproliferative disorders, such as polycythemia vera and thrombocythemia, secondary leukemias have been reported. It is unknown whether this leukemogenic effect is secondary to hydroxyurea or is associated with the patients’ underlying disease .



Commonly used brand name(s)

In the U.S.


  • Droxia

  • Hydrea

Available Dosage Forms:


  • Capsule

  • Tablet

Therapeutic Class: Antineoplastic Agent


Pharmacologic Class: Antimetabolite


Uses For hydroxyurea


Hydroxyurea is used to treat skin cancer (melanoma), a cancer of the white blood cells called chronic myelocytic leukemia (CML), and metastatic cancer (cancer that has spread) of the ovaries. hydroxyurea may also be given together with radiation treatment for head and neck cancer (primary squamous cell cancer).


Hydroxyurea is also used in adult patients with sickle cell anemia to prevent painful episodes and reduce the need for blood transfusions. It works by making the red blood cells more flexible.


Hydroxyurea will interfere with the growth of cancer cells, which are eventually destroyed. Since the growth of normal body cells may also be affected, other unwanted effects will also occur. Some of these effects may be serious and must be reported to your doctor.


Before you begin treatment with hydroxyurea, you and your doctor should talk about the good hydroxyurea will do as well as the risks of using it.


hydroxyurea is available only with your doctor's prescription.


Before Using hydroxyurea


In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For hydroxyurea, the following should be considered:


Allergies


Tell your doctor if you have ever had any unusual or allergic reaction to hydroxyurea or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.


Pediatric


Appropriate studies have not been performed on the relationship of age to the effects of hydroxyurea in the pediatric population. Safety and efficacy have not been established.


Geriatric


Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of hydroxyurea in the elderly. However, elderly patients are more likely to have age-related kidney problems, which may require caution and an adjustment in the dose for patients receiving hydroxyurea.


Pregnancy








Pregnancy CategoryExplanation
All TrimestersDStudies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy in a life threatening situation or a serious disease, may outweigh the potential risk.

Breast Feeding


There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.


Interactions with Medicines


Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are taking hydroxyurea, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.


Using hydroxyurea with any of the following medicines is not recommended. Your doctor may decide not to treat you with this medication or change some of the other medicines you take.


  • Rotavirus Vaccine, Live

Using hydroxyurea with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.


  • Adenovirus Vaccine Type 4, Live

  • Adenovirus Vaccine Type 7, Live

  • Bacillus of Calmette and Guerin Vaccine, Live

  • Didanosine

  • Influenza Virus Vaccine, Live

  • Measles Virus Vaccine, Live

  • Mumps Virus Vaccine, Live

  • Rotavirus Vaccine, Live

  • Rubella Virus Vaccine, Live

  • Smallpox Vaccine

  • Stavudine

  • Typhoid Vaccine

  • Varicella Virus Vaccine

  • Yellow Fever Vaccine

Interactions with Food/Tobacco/Alcohol


Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.


Other Medical Problems


The presence of other medical problems may affect the use of hydroxyurea. Make sure you tell your doctor if you have any other medical problems, especially:


  • Anemia (low red blood cells) or

  • Bone marrow problems or

  • Gout, history of or

  • Leukopenia (low white blood cells) or

  • Thrombocytopenia (low platelets)—May make these conditions worse.

  • HIV or AIDS infection with didanosine (Videx®) or stavudine (Zerit®) therapy—May cause side effects to become worse.

  • Kidney disease—Use with caution. The effects may be increased because of slower removal of the medicine from the body.

Proper Use of hydroxyurea


Take hydroxyurea exactly as directed by your doctor. Do not use more of it, do not use it more often, and do not use it for a longer time than your doctor ordered.


hydroxyurea comes with a patient information insert. Read and follow the instructions in the insert carefully. Ask your doctor if you have any questions.


Hydroxyurea should be handled with care and people who are not taking hydroxyurea should be careful to avoid touching it. To decrease the chance of touching the medicine:


  • Wear disposable gloves when handling hydroxyurea or bottles containing hydroxyurea.

  • Wash your hands before and after contact with the bottle or capsules.

  • If powder from the capsule is spilled, you should wipe it up immediately with a damp disposable towel and discard it in a closed container, such as a plastic bag.

  • You should keep medicine away from children and pets.

  • You should contact your doctor for instructions on how to dispose of capsules that are past the expiration date.

Dosing


The dose of hydroxyurea will be different for different patients. Follow your doctor's orders or the directions on the label. The following information includes only the average doses of hydroxyurea. If your dose is different, do not change it unless your doctor tells you to do so.


The amount of medicine that you take depends on the strength of the medicine. Also, the number of doses you take each day, the time allowed between doses, and the length of time you take the medicine depend on the medical problem for which you are using the medicine.


  • For oral dosage form (capsules):
    • For cancer of the head and neck, ovaries, or skin:
      • Adults—Dose is based on body weight and must be determined by your doctor. The dose is 80 milligrams (mg) per kilogram (kg) of body weight, taken as a single dose every third day.

      • Children—Use and dose must be determined by your doctor.


    • For chronic myelocytic leukemia (CML):
      • Adults—Dose is based on body weight and must be determined by your doctor. The dose is 30 milligrams (mg) per kilogram (kg) of body weight per day, taken as a single dose.

      • Children—Use and dose must be determined by your doctor.


    • For sickle cell anemia:
      • Adults—Dose is based on body weight and must be determined by your doctor. The dose is 15 milligrams (mg) per kilogram (kg) of body weight per day, taken as a single dose. Your doctor may increase your dose as needed. However, the dose is usually not more than 35 mg per kg of body weight per day.

      • Children—Use and dose must be determined by your doctor.



Missed Dose


If you miss a dose of hydroxyurea, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not double doses.


Storage


Store the medicine in a closed container at room temperature, away from heat, moisture, and direct light. Keep from freezing.


Keep out of the reach of children.


Do not keep outdated medicine or medicine no longer needed.


Ask your healthcare professional how you should dispose of any medicine you do not use.


Precautions While Using hydroxyurea


It is very important that your doctor check your progress at regular visits to make sure that hydroxyurea is working properly. Blood tests may be needed to check for unwanted effects.


Make sure your doctor knows if you are pregnant before you use hydroxyurea. Using hydroxyurea while you are pregnant can harm your unborn baby. If you think you have become pregnant while using the medicine, tell your doctor right away.


While you are being treated with hydroxyurea, and after you stop using it, do not have any immunizations (vaccines) without your doctor's approval. Hydroxyurea may lower your body's resistance and there is a chance you might get the infection the vaccine is meant to prevent. In addition, other persons living in your household should not get live vaccines (eg, nasal flu vaccine, measles, mumps, or rubella) since there is a chance they could pass the infection on to you. Also, avoid persons who have had a live vaccine. Do not get close to them and do not stay in the same room with them for very long. If you cannot take these precautions, you should consider wearing a protective face mask that covers the nose and mouth.


Hydroxyurea can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of platelets, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take, especially when your blood count is low, to reduce the risk of infection or bleeding:


  • If you can, avoid people with infections. Check with your doctor immediately if you think you are getting an infection or if you get a fever or chills, cough or hoarseness, lower back or side pain, or painful or difficult urination.

  • Check with your doctor immediately if you notice any unusual bleeding or bruising; black, tarry stools; blood in the urine or stools; or pinpoint red spots on your skin.

  • Be careful when using a regular toothbrush, dental floss, or toothpick. Your medical doctor, dentist, or nurse may recommend other ways to clean your teeth and gums. Check with your medical doctor before having any dental work done.

  • Do not touch your eyes or the inside of your nose unless you have just washed your hands and have not touched anything else in the meantime.

  • Be careful not to cut yourself when you are using sharp objects such as a safety razor or fingernail or toenail cutters.

  • Avoid contact sports or other situations where bruising or injury could occur.

Using hydroxyurea for a long time may increase your risk of developing cancer of the blood (leukemia). Talk to your doctor if you have concerns about this risk.


hydroxyurea may cause temporary loss of hair in some people. After treatment has ended, normal hair growth should return, although the new hair may be a slightly different color or texture.


Do not take other medicines unless they have been discussed with your doctor. This includes prescription or nonprescription (over-the-counter [OTC]) medicines and herbal or vitamin supplements.


hydroxyurea Side Effects


Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.


Check with your doctor immediately if any of the following side effects occur:


More common
  • Cough or hoarseness

  • fever or chills

  • lower back or side pain

  • painful or difficult urination

Less common
  • Black, tarry stools

  • blackening of the fingernails and toenails

  • blood in the urine or stools

  • pinpoint red spots on the skin

  • sores in the mouth and on the lips

  • unusual bleeding or bruising

Rare
  • Confusion

  • convulsions (seizures)

  • difficulty with urination

  • dizziness

  • headache

  • joint pain

  • seeing, hearing, or feeling things that are not there

  • swelling of the feet or lower legs

Incidence not known
  • Bleeding under the skin

  • blisters on the skin

  • bluish or pale color on the skin of the fingers or toes

  • coldness of the fingers or toes

  • crater-like lesions on the skin

  • itching skin

  • numbness or tingling of the fingers or toes

  • pain in the fingers or toes

  • unusual tiredness or weakness

  • weight loss

Get emergency help immediately if any of the following symptoms of overdose occur:


Symptoms of overdose
  • Scaling of the skin on the hands and feet

  • severe darkening of skin color

  • soreness

  • sores in the mouth and on the lips

  • swelling of the palms and soles of the feet

  • violet flushing of the skin

Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:


More common
  • Diarrhea

  • drowsiness

  • loss of appetite

  • nausea or vomiting

Less common
  • Constipation

  • redness of skin at the place of irradiation

  • skin rash and itching

Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.


Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.

See also: hydroxyurea side effects (in more detail)



The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.


The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.


More hydroxyurea resources


  • Hydroxyurea Side Effects (in more detail)
  • Hydroxyurea Use in Pregnancy & Breastfeeding
  • Drug Images
  • Hydroxyurea Drug Interactions
  • Hydroxyurea Support Group
  • 5 Reviews for Hydroxyurea - Add your own review/rating


  • hydroxyurea Concise Consumer Information (Cerner Multum)

  • Hydroxyurea Prescribing Information (FDA)

  • Hydroxyurea MedFacts Consumer Leaflet (Wolters Kluwer)

  • Hydroxyurea Professional Patient Advice (Wolters Kluwer)

  • Hydroxyurea Monograph (AHFS DI)

  • Droxia Prescribing Information (FDA)

  • Droxia MedFacts Consumer Leaflet (Wolters Kluwer)

  • Hydrea Prescribing Information (FDA)



Compare hydroxyurea with other medications


  • Anemia, Sickle Cell
  • Chronic Myelogenous Leukemia
  • Polycythemia Vera
  • Psoriasis
  • Psoriatic Arthritis
  • Solid Tumors

Hydrocodone and Acetaminophen Elixir




Generic Name: hydrocodone and acetaminophen

Dosage Form: Elixir CIII 5 mg/500 mg per 15 mL

Rx only


Code 539Z00


Rev.06/00



Hydrocodone and Acetaminophen Elixir Description


Hydrocodone bitartrate and acetaminophen is supplied in liquid form for oral administration.


Hydrocodone bitartrate is an opioid analgesic and antitussive and occurs as fine, white crystals or as a crystalline powder. It is affected by light. The chemical name is 4,5α-epoxy-3-methoxy-17-methylmorphinan-6-one tartrate (1:1) hydrate (2:5). It has the following structural formula:



C18H21NO3• C4H6O6• 2½H2O                                                                                 MW = 494.50


Acetaminophen, 4’-hydroxyacetanilide, a slightly bitter, white, odorless, crystalline powder, is a non-opiate, non-salicylate analgesic and antipyretic. It has the following structural formula:



C8H9NO2                                                                                                                  MW = 151.17


Hydrocodone bitartrate and acetaminophen elixir contains:


                                                               Per 5 mL                 Per 15 mL


Hydrocodone* Bitartrate...........................1.67 mg                        5 mg


(*Warning: May be habit forming)


Acetaminophen.........................................167 mg                    500 mg


Alcohol......................................................7.0%                        7.0%


In addition, the liquid contains the following inactive ingredients: Citric acid, ethyl maltol, glycerin, methylparaben, propylene glycol, propylparaben, purified water, saccharin sodium, sorbitol solution, sucrose, with D&C Yellow #10, FD&C Blue #1 and natural and artificial tropical fruit punch flavor.



Hydrocodone and Acetaminophen Elixir - Clinical Pharmacology


Hydrocodone is a semisynthetic narcotic analgesic and antitussive with multiple actions qualitatively similar to those of codeine. Most of these involve the central nervous system and smooth muscle. The precise mechanism of action of hydrocodone and other opiates is not known, although it is believed to relate to the existence of opiate receptors in the central nervous system. In addition to analgesia, narcotics may produce drowsiness, changes in mood and mental clouding.


The analgesic action of acetaminophen involves peripheral influences, but the specific mechanism is as yet undetermined. Antipyretic activity is mediated through hypothalamic heat regulating centers. Acetaminophen inhibits prostaglandin synthetase. Therapeutic doses of acetaminophen have negligible effects on the cardiovascular or respiratory systems; however, toxic doses may cause circulatory failure and rapid, shallow breathing.



Pharmacokinetics


The behavior of the individual components is described below.


Hydrocodone: Following a 10 mg oral dose of hydrocodone administered to five adult male subjects, the mean peak concentration was 23.6 ± 5.2 ng/mL. Maximum serum levels were achieved at 1.3 ± 0.3 hours and the half-life was determined to be 3.8 ± 0.3 hours. Hydrocodone exhibits a complex pattern of metabolism including O-demethylation, N-demethylation and 6-keto reduction to the corresponding 6-α- and 6-β-hydroxymetabolites.


See OVERDOSAGE for toxicity information.


Acetaminophen: Acetaminophen is rapidly absorbed from the gastrointestinal tract and is distributed throughout most body tissues. The plasma half-life is 1.25 to 3 hours, but may be increased by liver damage and following overdosage. Elimination of acetaminophen is principally by liver metabolism (conjugation) and subsequent renal excretion of metabolites. Approximately 85% of an oral dose appears in the urine within 24 hours of administration, most as the glucuronide conjugate, with small amounts of other conjugates and unchanged drug.


See OVERDOSAGE for toxicity information.



Indications and Usage for Hydrocodone and Acetaminophen Elixir


Hydrocodone bitartrate and acetaminophen elixir is indicated for the relief of moderate to moderately severe pain.



Contraindications


This product should not be administered to patients who have previously exhibited hypersensitivity to hydrocodone or acetaminophen.



Warnings



Respiratory Depression


At high doses or in sensitive patients, hydrocodone may produce dose-related respiratory depression by acting directly on the brain stem respiratory center. Hydrocodone also affects the center that controls respiratory rhythm, and may produce irregular and periodic breathing.



Head Injury and Increased Intracranial Pressure


The respiratory depressant effects of narcotics and their capacity to elevate cerebrospinal fluid pressure may be markedly exaggerated in the presence of head injury, other intracranial lesions or a preexisting increase in intracranial pressure. Furthermore, narcotics produce adverse reactions, which may obscure the clinical course of patients with head injuries.



Acute Abdominal Conditions


The administration of narcotics may obscure the diagnosis or clinical course of patients with acute abdominal conditions.



Precautions



General


Special Risk Patients

As with any narcotic analgesic agent, hydrocodone bitartrate and acetaminophen elixir should be used with caution in elderly or debilitated patients, and those with severe impairment of hepatic or renal function, hypothyroidism, Addison’s disease, prostatic hypertrophy or urethral stricture. The usual precautions should be observed and the possibility of respiratory depression should be kept in mind.


Cough Reflex

Hydrocodone suppresses the cough reflex; as with all narcotics, caution should be exercised when hydrocodone bitartrate and acetaminophen elixir is used postoperatively and in patients with pulmonary disease.



Information for Patients


Hydrocodone, like all narcotics, may impair mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery; patients should be cautioned accordingly.


Alcohol and other CNS depressants may produce an additive CNS depression, when taken with this combination product, and should be avoided.


Hydrocodone may be habit-forming. Patients should take the drug only for as long as it is prescribed, in the amounts prescribed, and no more frequently than prescribed.



Laboratory Tests


In patients with severe hepatic or renal disease, effects of therapy should be monitored with serial liver and/or renal function tests.



Drug Interactions


Patients receiving narcotics, antihistamines, antipsychotics, antianxiety agents, or other CNS depressants (including alcohol) concomitantly with hydrocodone bitartrate and acetaminophen elixir may exhibit an additive CNS depression. When combined therapy is contemplated, the dose of one or both agents should be reduced.


The use of MAO inhibitors or tricyclic antidepressants with hydrocodone preparations may increase the effect of either the antidepressant or hydrocodone.



Drug/Laboratory Test Interactions


Acetaminophen may produce false-positive test results for urinary 5-hydroxyindoleacetic acid.



Carcinogenesis, Mutagenesis, Impairment of Fertility


No adequate studies have been conducted in animals to determine whether hydrocodone or acetaminophen have a potential for carcinogenesis, mutagenesis, or impairment of fertility.



Pregnancy


Teratogenic Effects: Pregnancy Category C

There are no adequate and well-controlled studies in pregnant women. Hydrocodone bitartrate and acetaminophen elixir should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.


Nonteratogenic Effects

Babies born to mothers who have been taking opioids regularly prior to delivery will be physically dependent. The withdrawal signs include irritability and excessive crying, tremors, hyperactive reflexes, increased respiratory rate, increased stools, sneezing yawning, vomiting and fever. The intensity of the syndrome does not always correlate with the duration of maternal opioid use or dose. There is no consensus on the best method of managing withdrawal.



Labor and Delivery


As with all narcotics, administration of this product to the mother shortly before delivery may result in some degree of respiratory depression in the newborn, especially if higher doses are used.



Nursing Mothers


Acetaminophen is excreted in breast milk in small amounts, but the significance of its effects on nursing infants is not known. It is not known whether hydrocodone is excreted in human milk. Because many drugs are excreted in human milk and because of the potential for serious adverse reactions in nursing infants from hydrocodone and acetaminophen, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.



Pediatric Use


Safety and effectiveness in pediatric patients have not been established.



Adverse Reactions


The most frequently reported adverse reactions are lightheadedness, dizziness, sedation, nausea and vomiting. These effects seem to be more prominent in ambulatory than in nonambulatory patients and some of these adverse reactions may be alleviated if the patient lies down.


Other adverse reactions include:


Central Nervous System/Psychiatric: Drowsiness, mental clouding, lethargy, impairment of mental and physical performance, anxiety, fear, dysphoria, psychic dependence, mood changes.


Gastrointestinal System: Prolonged administration of hydrocodone bitartrate and acetaminophen elixir may produce constipation.


Genitourinary System: Ureteral spasm, spasm of vesical sphincters, and urinary retention have been reported with opiates.


Respiratory Depression: Hydrocodone bitartrate may produce dose-related respiratory depression by acting directly on the brain stem respiratory centers (see OVERDOSAGE).


Dermatological: Skin rash, pruritus.


The following adverse drug events may be borne in mind as potential effects of acetaminophen: allergic reactions, rash, thrombocytopenia, agranulocytosis.


Potential effects of high dosage are listed in the OVERDOSAGE section.



Drug Abuse and Dependence



Controlled Substance


Hydrocodone bitartrate and acetaminophen elixir is classified as a Schedule III controlled substance.



Abuse and Dependence


Psychic dependence, physical dependence, and tolerance may develop upon repeated administration of narcotics; therefore, this product should be prescribed and administered with caution. However, psychic dependence is unlikely to develop when hydrocodone bitartrate and acetaminophen elixir is used for a short time for the treatment of pain.


Physical dependence, the condition in which continued administration of the drug is required to prevent the appearance of a withdrawal syndrome, assumes clinically significant proportions only after several weeks of continued narcotic use, although some mild degree of physical dependence may develop after a few days of narcotic therapy. Tolerance, in which increasingly large doses are required in order to produce the same degree of analgesia, is manifested initially by a shortened duration of analgesic effect, and subsequently by decreases in the intensity of analgesia. The rate of development of tolerance varies among patients.



Overdosage


Following an acute overdosage, toxicity may result from hydrocodone or acetaminophen.



Signs and Symptoms


Hydrocodone:  Serious overdose with hydrocodone is characterized by respiratory depression (a decrease in respiratory rate and/or tidal volume, Cheyne-Stokes respiration, cyanosis), extreme somnolence progressing to stupor or coma, skeletal muscle flaccidity, cold and clammy skin, and sometimes bradycardia and hypotension. In severe overdosage, apnea, circulatory collapse, cardiac arrest and death may occur.


Acetaminophen:  In acetaminophen overdosage: dose-dependent, potentially fatal hepatic necrosis is the most serious adverse effect. Renal tubular necrosis, hypoglycemic coma, and thrombocytopenia may also occur.


Early symptoms following a potentially hepatotoxic overdose may include: nausea, vomiting, diaphoresis and general malaise. Clinical and laboratory evidence of hepatic toxicity may not be apparent until 48 to 72 hours post-ingestion.


In adults, hepatic toxicity has rarely been reported with acute overdoses of less than 10 grams, or fatalities with less than 15 grams.



Treatment


 A single or multiple overdose with hydrocodone and acetaminophen is a potentially lethal polydrug overdose, and consultation with a regional poison control center is recommended.


Immediate treatment includes support of cardiorespiratory function and measures to reduce drug absorption. Vomiting should be induced mechanically, or with syrup of ipecac, if the patient is alert (adequate pharyngeal and laryngeal reflexes). Oral activated charcoal (1 g/kg) should follow gastric emptying. The first dose should be accompanied by an appropriate cathartic. If repeated doses are used, the cathartic might be included with alternate doses as required. Hypotension is usually hypovolemic and should respond to fluids. Vasopressors and other supportive measures should be employed as indicated. A cuffed endotracheal tube should be inserted before gastric lavage of the unconscious patient and, when necessary, to provide assisted respiration.


Meticulous attention should be given to maintaining adequate pulmonary ventilation. In severe cases of intoxication, peritoneal dialysis, or preferably hemodialysis may be considered. If hypoprothrombinemia occurs due to acetaminophen overdose, vitamin K should be administered intravenously.


Naloxone, a narcotic antagonist, can reverse respiratory depression and coma associated with opioid overdose. Naloxone hydrochloride 0.4 mg to 2 mg is given parenterally. Since the duration of action of hydrocodone may exceed that of the naloxone, the patient should be kept under continuous surveillance and repeated doses of the antagonist should be administered as needed to maintain adequate respiration. A narcotic antagonist should not be administered in the absence of clinically significant respiratory or cardiovascular depression.


If the dose of acetaminophen may have exceeded 140 mg/kg, acetylcysteine should be administered as early as possible. Serum acetaminophen levels should be obtained, since levels four or more hours following ingestion help predict acetaminophen toxicity. Do not await acetaminophen assay results before initiating treatment. Hepatic enzymes should be obtained initially, and repeated at 24-hour intervals.


Methemoglobinemia over 30% should be treated with methylene blue by slow intravenous administration.


The toxic dose for adults for acetaminophen is 10g.



Hydrocodone and Acetaminophen Elixir Dosage and Administration


Dosage should be adjusted according to severity of pain and response of the patient. However, it should be kept in mind that tolerance to hydrocodone can develop with continued use and that the incidence of untoward effects is dose-related.


The usual adult dosage is one or two tablespoonfuls (15-30 mL) every four to six hours as needed for pain. The total daily dosage should not exceed 8 tablespoonfuls.



How is Hydrocodone and Acetaminophen Elixir Supplied


Hydrocodone bitartrate and acetaminophen elixir is a green, tropical fruit punch flavored liquid containing hydrocodone* bitartrate 5 mg (*WARNING: May be habit forming) and acetaminophen 500 mg per 15 mL, with 7.0% alcohol, and is supplied in containers of 118 mL (4 fl oz), NDC 46672-578-04, in containers of 473 mL (16 fl oz), NDC 46672-578-16, and in containers of 3.785L (1 gallon), NDC 46672-578-28.


 



Storage


Store at controlled room temperature, 15° to 30°C (59° to 86°F) (See USP).


Dispense in a tight, light-resistant container with a child-resistant closure.



Rx only


Manufactured by


Mikart Inc.


Atlanta, GA 30318


Rev. 06 / 00                                                                                                                     Code 539Z00








HYDROCODONE BITARTRATE AND ACETAMINOPHEN 
hydrocodone bitartrate and acetaminophen  elixir










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)46672-578
Route of AdministrationORALDEA ScheduleCII    


















































INGREDIENTS
Name (Active Moiety)TypeStrength
HYDROCODONE BITARTRATE (HYDROCODONE)Active5 MILLIGRAM  In 15 MILLILITER
ACETAMINOPHEN (ACETAMINOPHEN)Active500 MILLIGRAM  In 15 MILLILITER
CITRIC ACIDInactive 
D & C YELLOW #10Inactive 
ETHYL MATOLInactive 
FD & C BLUE #1Inactive 
GLYCERINInactive 
METHYLPARABENInactive 
NATURAL AND ARTIFICIAL TROPICAL FRUIT PUNCH FLAVORInactive 
PROPYLENE GLYCOLInactive 
PROPYLPARABENInactive 
WATERInactive 
SACCHARIN SODIUMInactive 
SORBITOL SOLUTIONInactive 
SUCROSEInactive 


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      


















Packaging
#NDCPackage DescriptionMultilevel Packaging
146672-578-16473 mL (MILLILITER) In 1 BOTTLE, PLASTICNone
246672-578-04118 mL (MILLILITER) In 1 BOTTLE, PLASTICNone
346672-578-283.785 L (LITER) In 1 BOTTLE, PLASTICNone

Revised: 06/2006Mikart Inc.

More Hydrocodone and Acetaminophen Elixir resources


  • Hydrocodone and Acetaminophen Elixir Side Effects (in more detail)
  • Hydrocodone and Acetaminophen Elixir Use in Pregnancy & Breastfeeding
  • Drug Images
  • Hydrocodone and Acetaminophen Elixir Drug Interactions
  • Hydrocodone and Acetaminophen Elixir Support Group
  • 370 Reviews for Hydrocodone and Acetaminophen - Add your own review/rating


Compare Hydrocodone and Acetaminophen Elixir with other medications


  • Back Pain
  • Cough
  • Pain
  • Rheumatoid Arthritis

Hydrocodone/Ibuprofen


Pronunciation: HYE-droe-KOE-done/EYE-bue-PROE-fen
Generic Name: Hydrocodone/Ibuprofen
Brand Name: Examples include Reprexain and Vicoprofen


Hydrocodone/Ibuprofen is used for:

Short-term treatment of pain.


Hydrocodone/Ibuprofen is an opioid analgesic and nonsteroidal anti-inflammatory drug (NSAID) combination. Exactly how it works is not known. Ibuprofen may block certain substances in the body that cause inflammation. Hydrocodone may affect opiate receptors in the brain to decrease pain.


Do NOT use Hydrocodone/Ibuprofen if:


  • you are allergic to any ingredient in Hydrocodone/Ibuprofen

  • you have had a severe allergic reaction (eg, severe rash, hives, trouble breathing, growths in the nose, dizziness) to aspirin or an NSAID (eg, ibuprofen, celecoxib)

  • you have severe kidney problems or you have severe diarrhea or other bowel problems caused by antibiotics or food poisoning

  • you have recently had or will be having bypass heart surgery

  • you are in the last 3 months of pregnancy

  • you take sodium oxybate (GHB) or you have taken a monoamine oxidase inhibitor (MAOI) (eg, phenelzine) within the past 14 days

Contact your doctor or health care provider right away if any of these apply to you.



Before using Hydrocodone/Ibuprofen:


Some medical conditions may interact with Hydrocodone/Ibuprofen. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you are allergic to other narcotic medicines (eg, medicines that contain codeine, morphine, oxycodone)

  • if you or a family member has a history of mental or mood problems, suicidal thoughts or attempts, or alcohol or substance abuse, or if you drink alcohol

  • if you have a history of kidney, liver, or lung problems, diabetes, or stomach or bowel problems (eg, bleeding, perforation, ulcers)

  • if you have a history of swelling or fluid buildup, lupus, asthma, growths in the nose (nasal polyps), or mouth inflammation

  • if you have high blood pressure, blood disorders, bleeding or clotting problems, heart problems (eg, heart failure), or blood vessel problems, or if you are at risk for any of these problems

  • if you have Addison disease, thyroid problems, an enlarged prostate, or trouble urinating

  • if you have asthma or breathing problems, seizures, growths in the brain, a recent head injury, or if you have had recent surgery

  • if you have poor health, dehydration or low fluid volume, or low blood sodium levels

Some MEDICINES MAY INTERACT with Hydrocodone/Ibuprofen. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Anticoagulants (eg, warfarin), corticosteroids (eg, prednisone), heparin, salicylates (eg, aspirin), or selective serotonin reuptake inhibitors (SSRIs) (eg, fluoxetine) because the risk of bleeding, including stomach bleeding, may be increased

  • Antihistamines (eg, diphenhydramine), barbiturates (eg, phenobarbital), cimetidine, narcotic pain medicine (eg, codeine), or sodium oxybate (GHB) because the risk of excessive drowsiness or severe breathing problems may be increased

  • Anticholinergics (eg, benztropine), MAOIs (eg, phenelzine), probenecid, or tricyclic antidepressants (eg, amitriptyline) because they may increase the risk of Hydrocodone/Ibuprofen's side effects

  • Naltrexone or rifampin because they may decrease Hydrocodone/Ibuprofen's effectiveness

  • Cyclosporine, lithium, methotrexate, or quinolones (eg, ciprofloxacin) because the risk of their side effects may be increased by Hydrocodone/Ibuprofen

  • Angiotensin-converting enzyme (ACE) inhibitors (eg, enalapril) or diuretics (eg, furosemide, hydrochlorothiazide) because their effectiveness may be decreased by Hydrocodone/Ibuprofen

This may not be a complete list of all interactions that may occur. Ask your health care provider if Hydrocodone/Ibuprofen may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Hydrocodone/Ibuprofen:


Use Hydrocodone/Ibuprofen as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Hydrocodone/Ibuprofen comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Hydrocodone/Ibuprofen refilled.

  • Take Hydrocodone/Ibuprofen by mouth with or without food. If stomach upset occurs, take with food to reduce stomach irritation.

  • If you miss a dose of Hydrocodone/Ibuprofen and you are taking it regularly, take it as soon as possible. If several hours have passed or if it is nearing time for the next dose, do not double the dose to catch up, unless advised by your health care provider. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Hydrocodone/Ibuprofen.



Important safety information:


  • Hydrocodone/Ibuprofen may cause dizziness or drowsiness. These effects may be worse if you take it with alcohol or certain medicines. Use Hydrocodone/Ibuprofen with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Hydrocodone/Ibuprofen; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Serious stomach ulcers or bleeding can occur with the use of Hydrocodone/Ibuprofen. Taking it in high doses or for a long time, smoking, or drinking alcohol increases the risk of these side effects. Taking Hydrocodone/Ibuprofen with food will NOT reduce the risk of these effects. Contact your doctor or emergency room at once if you develop severe stomach or back pain; black, tarry stools; vomit that looks like blood or coffee grounds; or unusual weight gain or swelling.

  • Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor.

  • Hydrocodone/Ibuprofen has ibuprofen in it. Before you start any new medicine, check the label to see if it has ibuprofen in it too. If it does or you are not sure, check with your doctor or pharmacist.

  • Do not take aspirin while you take Hydrocodone/Ibuprofen unless your doctor tells you to. If you already take aspirin for a heart or other condition, talk with your doctor about whether or not you should continue to take it with Hydrocodone/Ibuprofen.

  • Lab tests, including liver function, kidney function, complete blood cell counts, and blood pressure, may be performed while you use Hydrocodone/Ibuprofen. These tests may be used to monitor your condition or check for side effects. Be sure to keep all doctor and lab appointments.

  • Use Hydrocodone/Ibuprofen with caution in the ELDERLY; they may be more sensitive to its effects, especially stomach bleeding.

  • Hydrocodone/Ibuprofen should be used with extreme caution in CHILDREN younger than 16 years old; safety and effectiveness in these children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: Hydrocodone/Ibuprofen may cause harm to the fetus. Do not take it during the last 3 months of pregnancy. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Hydrocodone/Ibuprofen while you are pregnant. It is not known if Hydrocodone/Ibuprofen is found in breast milk. Do not breast-feed while taking Hydrocodone/Ibuprofen.

When used for long periods of time or at high doses, Hydrocodone/Ibuprofen may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Hydrocodone/Ibuprofen stops working well. Do not take more than prescribed.


Some people who use Hydrocodone/Ibuprofen for a long time may develop a need to continue taking it. People who take high doses are also at risk. This is known as DEPENDENCE or addiction.


If you suddenly stop taking Hydrocodone/Ibuprofen, you may experience WITHDRAWAL symptoms, including anxiety; diarrhea; fever, runny nose, or sneezing; goose bumps and abnormal skin sensations; nausea; vomiting; pain; rigid muscles; rapid heartbeat; seeing, hearing, or feeling things that are not there; shivering or tremors; sweating; and trouble sleeping.



Possible side effects of Hydrocodone/Ibuprofen:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Anxiety; constipation; diarrhea; dizziness; dry mouth; gas; headache; heartburn; increased sweating; loss of appetite; nausea; nervousness; stomach pain or upset; trouble sleeping; vomiting; weakness.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); bloody, black, or tarry stools; blurred vision; change in the amount of urine produced; chest pain; confusion; dark urine; depression; fainting; fast or irregular heartbeat; fever, chills, or persistent sore throat; mental or mood changes; numbness of an arm or leg; one-sided weakness; red, swollen, blistered, or peeling skin; ringing in the ears; seizures; severe headache or dizziness; severe or persistent stomach pain or nausea; severe vomiting; shortness of breath; slow or shallow breathing; stiff neck; sudden or unexplained weight gain; swelling of hands, legs, or feet; unusual bruising or bleeding; unusual joint or muscle pain; unusual tiredness or weakness; vision or speech changes; vomit that looks like coffee grounds; yellowing of the skin or eyes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Hydrocodone/Ibuprofen side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include blurred vision; cold and clammy skin; coma; confusion; decreased urination; loss of consciousness; ringing in the ears; severe dizziness or drowsiness; severe muscle weakness; severe nausea or stomach pain; slow or troubled breathing; unusual bleeding or bruising; vomit that looks like coffee grounds.


Proper storage of Hydrocodone/Ibuprofen:

Store Hydrocodone/Ibuprofen at 77 degrees F (25 degrees C). Brief storage at temperatures between 59 and 86 degrees F (15 and 30 degrees C) is permitted. Store away from heat, moisture, and light. Do not store in the bathroom. Keep Hydrocodone/Ibuprofen out of the reach of children and away from pets.


General information:


  • If you have any questions about Hydrocodone/Ibuprofen, please talk with your doctor, pharmacist, or other health care provider.

  • Hydrocodone/Ibuprofen is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Hydrocodone/Ibuprofen. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Hydrocodone/Ibuprofen resources


  • Hydrocodone/Ibuprofen Side Effects (in more detail)
  • Hydrocodone/Ibuprofen Use in Pregnancy & Breastfeeding
  • Drug Images
  • Hydrocodone/Ibuprofen Drug Interactions
  • Hydrocodone/Ibuprofen Support Group
  • 42 Reviews for Hydrocodone/Ibuprofen - Add your own review/rating


Compare Hydrocodone/Ibuprofen with other medications


  • Pain

Hydroxyzine



Pronunciation: hye-DROX-i-zeen
Generic Name: Hydroxyzine
Brand Name: Hyzine


Hydroxyzine is used for:

Treating anxiety. It is also used to cause sedation before and after general anesthesia. It is also used to treat itching due to certain allergic conditions, including hives and contact dermatitis (eg, poison ivy). It also may be used for other conditions as determined by your doctor.


Hydroxyzine is an antihistamine. It works by affecting the brain to reduce anxiety. It also has other activities, including opening breathing tubes, relieving pain or allergy symptoms, and preventing or treating nausea and vomiting caused by motion sickness.


Do NOT use Hydroxyzine if:


  • you are allergic to any ingredient in Hydroxyzine

  • you are taking sodium oxybate (GHB)

  • you are in your first 3 months of pregnancy

Contact your doctor or health care provider right away if any of these apply to you.



Video: Treatment for Depression







Treatments for depression are getting better everyday and there are things you can start doing right away.






Before using Hydroxyzine:


Some medical conditions may interact with Hydroxyzine. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have asthma, glaucoma, difficulty urinating, urinary or intestinal blockage, prostate disease, or a blood disease

  • if you consume alcoholic beverages

Some MEDICINES MAY INTERACT with Hydroxyzine. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Ethanol or (sodium oxybate) GHB because side effects such as an increase in sleep duration and slowed breathing may occur

This may not be a complete list of all interactions that may occur. Ask your health care provider if Hydroxyzine may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Hydroxyzine:


Use Hydroxyzine as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Hydroxyzine is usually given as an injection at your doctor's office, hospital, or clinic. If you will be using Hydroxyzine at home, a health care provider will teach you how to use it. Be sure you understand how to use Hydroxyzine. Follow the procedures you are taught when you use a dose. Contact your health care provider if you have any questions.

  • Do not use Hydroxyzine if it contains particles, is cloudy or discolored, or if the vial is cracked or damaged.

  • Keep this product, as well as syringes and needles, out of the reach of children and pets. Do not reuse needles, syringes, or other materials. Ask your health care provider how to dispose of these materials after use. Follow all local rules for disposal.

  • If you miss a dose of Hydroxyzine and you are using it regularly, take it as soon as possible. If it is almost time for you next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Hydroxyzine.



Important safety information:


  • Hydroxyzine may cause drowsiness. These effects may be worse if you take it with alcohol or certain medicines. Use Hydroxyzine with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Avoid drinking alcohol or using medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you are using Hydroxyzine; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Use Hydroxyzine with caution in the ELDERLY; they may be more sensitive to its effects.

  • Hydroxyzine should not be used in NEWBORNS; safety and effectiveness in newborns have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: Do not use Hydroxyzine if you are in your first 3 months of pregnancy. If you think you may be pregnant, contact your doctor right away. It is not known if Hydroxyzine is found in breast milk. Do not breast-feed while taking Hydroxyzine.


Possible side effects of Hydroxyzine:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Drowsiness; dry mouth.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); involuntary movements.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Hydroxyzine side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (http://www.aapcc.org ), or emergency room immediately. Symptoms may include unusual dizziness and drowsiness.


Proper storage of Hydroxyzine:

Store Hydroxyzine at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). Store away from heat, moisture, and light. Keep Hydroxyzine out of the reach of children and away from pets.


General information:


  • If you have any questions about Hydroxyzine, please talk with your doctor, pharmacist, or other health care provider.

  • Hydroxyzine is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Hydroxyzine. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Hydroxyzine resources


  • Hydroxyzine Side Effects (in more detail)
  • Hydroxyzine Use in Pregnancy & Breastfeeding
  • Drug Images
  • Hydroxyzine Drug Interactions
  • Hydroxyzine Support Group
  • 99 Reviews for Hydroxyzine - Add your own review/rating


  • Hydroxyzine Prescribing Information (FDA)

  • Hydroxyzine Professional Patient Advice (Wolters Kluwer)

  • Atarax Consumer Overview

  • Atarax Prescribing Information (FDA)

  • Hydroxyzine Hydrochloride Monograph (AHFS DI)

  • Vistaril Prescribing Information (FDA)

  • Vistaril Consumer Overview



Compare Hydroxyzine with other medications


  • Allergic Urticaria
  • Allergies
  • Anxiety
  • Interstitial Cystitis
  • Nausea/Vomiting
  • Pain
  • Pruritus
  • Sedation

Hex-Tra




Generic Name: chlorhexidine gluconate liquid

Dosage Form: FOR ANIMAL USE ONLY
Hex-Tra

USE DIRECTIONS:

Use at full strength, do not dilute.




POST-MILKING:


Dip entire teat in Hex-Tra.  Allow to air dry.

If solution in cup becomes visibly dirty.  Then

replenish with Hex-Tra at full strength.  Do

not return unused product to original container.



PROTECT FROM FREEZING

IF FROZEN: SHAKE VIGOROUSLY

AFTER THAWING

WARNING:  CONTAINS CHLORHEXIDINE

GLUCONATE.


Not for human use.

Avoid contamination of food.  Avoid contact

with eyes.  Not for internal use.




OBSERVE LABEL DIRECTIONS


KEEP OUT OF REACH OF CHILDREN!


FIRST AID:

INTERNAL:  If swallowed, do not induce vomiting.

Drink large quantities of water.  See physician immediately.


EYES:  Flush eyes with clear water for 15 minutes.If irritated, obtain medical guidance.



GET MEDICAL ATTENTION IMMEDIATELY.

Hex-Tra


SANITIZING CHLORHEXIDINE TEAT DIP

FORMULATED WITH EMOLLIENTS AND

DERMAL CONDITIONERS




This product, when properly used, is effective as an aid

in reducing the spread of organisms which may cause

mastitis.


Active Ingredient..........0.50% Chlorhexidine Gluconate


Contains an Emollient System


Lot#:______________________

Exp. Date:___________________


Next Content:________________



Manufactured For:

Tetradyne LLC

PO Box 17003

Reno, NV 89511










Hex-Tra 
teat dip  liquid










Product Information
Product TypeOTC ANIMAL DRUGNDC Product Code (Source)66399-083
Route of AdministrationTOPICALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
CHLORHEXIDINE GLUCONATE (CHLORHEXIDINE)CHLORHEXIDINE GLUCONATE0.50 L  in 100 L






Inactive Ingredients
Ingredient NameStrength
GLYCERIN5.0 L  in 100 L


















Product Characteristics
Color    Score    
ShapeSize
FlavorImprint Code
Contains      


































Packaging
#NDCPackage DescriptionMultilevel Packaging
166399-083-013.78 L In 1 JUGNone
266399-083-0218.9 L In 1 PAILNone
366399-083-0356.7 L In 1 DRUMNone
466399-083-04113.4 L In 1 DRUMNone
566399-083-05207.9 L In 1 DRUMNone
666399-083-06945 L In 1 CONTAINER, FLEXIBLE INTERMEDIATE BULKNone
766399-083-071039.5 L In 1 CONTAINER, FLEXIBLE INTERMEDIATE BULKNone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
unapproved drug other09/10/2001


Labeler - Tetradyne LLC (130969293)
Revised: 11/2010Tetradyne LLC



Hydromorphone Suppository



Pronunciation: HYE-droe-MOR-fone
Generic Name: Hydromorphone
Brand Name: Dilaudid


Hydromorphone Suppository is used for:

Treating pain in certain patients.


Hydromorphone Suppository is an opioid (narcotic) analgesic. It works by binding to certain receptors in the brain and nervous system to reduce pain.


Do NOT use Hydromorphone Suppository if:


  • you are allergic to any ingredient in Hydromorphone Suppository or any other codeine- or morphine-related medicine (eg, morphine, codeine, oxycodone)

  • you have difficult or slowed breathing, chronic obstructive pulmonary disease (COPD), or right-sided heart problems (cor pulmonale), or you are having a severe asthma attack

  • you are in labor

  • you have severe diarrhea or other bowel problems caused by antibiotics or poisoning

  • you have a brain injury or growths in the brain along with increased pressure in the brain

  • you are taking sodium oxybate (GHB)

Contact your doctor or health care provider right away if any of these apply to you.



Before using Hydromorphone Suppository:


Some medical conditions may interact with Hydromorphone Suppository. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:


  • if you are pregnant, planning to become pregnant, or are breast-feeding

  • if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement

  • if you have allergies to medicines, foods, or other substances

  • if you have a history of lung or breathing problems (eg, asthma, emphysema, bronchitis), seizures (eg, epilepsy), adrenal gland problems, an enlarged prostate, heart problems, low blood pressure, dehydration, low blood volume, an underactive thyroid, or urinary blockage

  • if you have severe drowsiness, a recent head injury, spinal problems, growths in the brain, or increased pressure in the brain

  • if you have liver or kidney problems, gallbladder problems, or stomach or bowel problems (eg, inflammation), or if you have had recent stomach or bowel surgery

  • if you drink alcohol regularly, have symptoms of alcohol withdrawal, or have a history of suicidal thoughts or attempts

  • if you have a personal or family history of mental or mood problems, alcohol abuse, or other substance abuse or dependence

  • if you are in poor health or shock, or will be having surgery

Some MEDICINES MAY INTERACT with Hydromorphone Suppository. Tell your health care provider if you are taking any other medicines, especially any of the following:


  • Phenothiazines (eg, chlorpromazine) because the risk of low blood pressure may be increased

  • Barbiturate anesthetics (eg, thiopental), cimetidine, or sodium oxybate (GHB) because the risk of severe drowsiness, coma, or slowed or difficult breathing may be increased

  • Agonist/antagonist analgesics (eg, pentazocine) or naltrexone because they may decrease Hydromorphone Suppository's effectiveness and withdrawal may occur

This may not be a complete list of all interactions that may occur. Ask your health care provider if Hydromorphone Suppository may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.


How to use Hydromorphone Suppository:


Use Hydromorphone Suppository as directed by your doctor. Check the label on the medicine for exact dosing instructions.


  • Wash your hands before and after using Hydromorphone Suppository.

  • If the suppository is too soft to use, put it in the refrigerator for about 15 minutes. You may also run cold water over it.

  • Remove the wrapper. Moisten the suppository with cool water. Lie down on your side. Insert the pointed end of the suppository into the rectum. Use your finger to push it in completely.

  • If you are taking Hydromorphone Suppository for persistent pain, take it on a regular schedule to help control the pain more effectively.

  • Do not change your dose or suddenly stop taking Hydromorphone Suppository without checking with your doctor.

  • If Hydromorphone Suppository is no longer needed, dispose of it as soon as possible. Ask your doctor or pharmacist how to dispose of Hydromorphone Suppository properly.

  • If you miss a dose of Hydromorphone Suppository and you are taking it regularly, take it as soon as possible. If several hours have passed or if it is nearing time for the next dose, do not double the dose to catch up, unless advised by your health care provider. Do not take 2 doses at once.

Ask your health care provider any questions you may have about how to use Hydromorphone Suppository.



Important safety information:


  • Hydromorphone Suppository may cause drowsiness, dizziness, blurred vision, or lightheadedness. These effects may be worse if you take it with alcohol, other opiate pain medicines, or certain other medicines. Use Hydromorphone Suppository with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.

  • Do not drink alcohol or use medicines that may cause drowsiness (eg, sleep aids, muscle relaxers) while you take Hydromorphone Suppository; it may add to their effects. Ask your pharmacist if you have questions about which medicines may cause drowsiness.

  • Hydromorphone Suppository may cause dizziness, lightheadedness, or fainting; alcohol, hot weather, exercise, or fever may increase these effects. To prevent them, sit up or stand slowly, especially in the morning. Sit or lie down at the first sign of any of these effects.

  • Hydromorphone Suppository may be habit-forming. Do NOT take more than the recommended dose or use for longer than prescribed without checking with your doctor. Misuse or abuse of Hydromorphone Suppository may cause severe side effects, including severe breathing problems, seizures, coma, and possibly death.

  • Constipation is a common side effect of Hydromorphone Suppository. Talk to your doctor about using laxatives or stool softeners to prevent or treat constipation while you use Hydromorphone Suppository.

  • If your pain continues or becomes worse or if you have side effects that concern you, contact your doctor.

  • Tell your doctor or dentist that you take Hydromorphone Suppository before you receive any medical or dental care, emergency care, or surgery.

  • Use Hydromorphone Suppository with caution in the ELDERLY; they may be more sensitive to its effects, especially drowsiness and breathing problems.

  • Hydromorphone Suppository should be used with extreme caution in CHILDREN; safety and effectiveness in children have not been confirmed.

  • PREGNANCY and BREAST-FEEDING: Hydromorphone Suppository may cause harm to the fetus. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Hydromorphone Suppository while you are pregnant. Hydromorphone Suppository is found in breast milk. Do not breast-feed while taking Hydromorphone Suppository.

When used for long periods of time or at high doses, Hydromorphone Suppository may not work as well and may require higher doses to obtain the same effect as when originally taken. This is known as TOLERANCE. Talk with your doctor if Hydromorphone Suppository stops working well. Do not take more than prescribed.


Some people who use Hydromorphone Suppository for a long time may develop a need to continue taking it. People who take high doses are also at risk. This is known as DEPENDENCE or addiction. Dependence is unlikely to be an issue in terminally ill patients where comfort is more important. If you are taking Hydromorphone Suppository regularly, do not suddenly stop taking it without checking with your doctor. WITHDRAWAL symptoms have occurred when Hydromorphone Suppository is suddenly stopped and may include anxiety; diarrhea; fever, runny nose, or sneezing; goose bumps and abnormal skin sensations; nausea and vomiting; pain; rigid muscles; seeing, hearing, or feeling things that are not there; shivering or tremors; sweating; and trouble sleeping. Contact your doctor if you notice any of these symptoms after stopping Hydromorphone Suppository.



Possible side effects of Hydromorphone Suppository:


All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:



Constipation; dizziness, drowsiness; dry mouth; flushing; lightheadedness; nausea; sweating; vomiting.



Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); fainting; fast, slow, or irregular heartbeat; hallucinations; mental or mood changes; seizure or persistent dizziness or drowsiness; severe or persistent headache or vomiting; shallow, slowed or difficult breathing; tremor; trouble urinating; vision changes.



This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.


See also: Hydromorphone side effects (in more detail)


If OVERDOSE is suspected:


Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include bluish skin; chest pain; cold and clammy skin; coma; difficult or slow breathing; excessive sweating; limp muscles; nausea and vomiting; numbness of an arm or leg; pinpoint pupils; seizures; severe drowsiness or dizziness; slow or irregular heartbeat.


Proper storage of Hydromorphone Suppository:

Store Hydromorphone Suppository in the refrigerator, between 36 and 46 degrees F (2 and 8 degrees C). Do not freeze. Keep Hydromorphone Suppository out of the reach of children and away from pets.


General information:


  • If you have any questions about Hydromorphone Suppository, please talk with your doctor, pharmacist, or other health care provider.

  • Hydromorphone Suppository is to be used only by the patient for whom it is prescribed. Do not share it with other people.

  • If your symptoms do not improve or if they become worse, check with your doctor.

  • Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Hydromorphone Suppository. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.



Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Hydromorphone resources


  • Hydromorphone Side Effects (in more detail)
  • Hydromorphone Use in Pregnancy & Breastfeeding
  • Drug Images
  • Hydromorphone Drug Interactions
  • Hydromorphone Support Group
  • 165 Reviews for Hydromorphone - Add your own review/rating


Compare Hydromorphone with other medications


  • Anesthetic Adjunct
  • Cough
  • Pain

Hydroxyzine Pamoate




Dosage Form: capsule
Hydroxyzine Pamoate Capsules USP

 


Rx only



Hydroxyzine Pamoate Description


Hydroxyzine Pamoate is a light yellow, practically odorless powder practically insoluble in water and methanol and freely soluble in dimethylformamide. It is chemically designated as (±)-2-[2-[4-(p-Chloro-α-phenylbenzyl)-1-piperazinyl]ethoxy]ethanol 4,4’-methylenebis[3-hydroxy-2-naphthoate] (1:1) [10246-75-0] and can be structurally represented as follows:



C21H27CIN2O2•C23H16O6


M.W. 763.27


Each capsule, for oral administration, contains Hydroxyzine Pamoate equivalent to hydroxyzine hydrochloride 25 mg or 50 mg. In addition, each capsule contains the following inactive ingredients: colloidal silicon dioxide, D&C yellow No. 10, FD&C green No. 3, FD&C yellow No. 6, gelatin, hydroxypropyl cellulose, lactose monohydrate, magnesium stearate, propylene glycol, sodium lauryl sulfate, sodium starch glycolate and titanium dioxide.



Hydroxyzine Pamoate - Clinical Pharmacology


Hydroxyzine Pamoate capsules are unrelated chemically to the phenothiazines, reserpine, meprobamate or the benzodiazepines.


Hydroxyzine Pamoate capsules are not a cortical depressant, but their action may be due to a suppression of activity in certain key regions of the subcortical area of the central nervous system. Primary skeletal muscle relaxation has been demonstrated experimentally. Bronchodilator activity and antihistaminic and analgesic effects have been demonstrated experimentally and confirmed clinically.


An antiemetic effect, both by the apomorphine test and the veriloid test, has been demonstrated. Pharmacological and clinical studies indicate that hydroxyzine in therapeutic dosage does not increase gastric secretion or acidity and in most cases has mild antisecretory activity.


Hydroxyzine is rapidly absorbed from the gastrointestinal tract and Hydroxyzine Pamoate capsules clinical effects are usually noted within 15 to 30 minutes after oral administration.



INDICATIONS


For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested.


Useful in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses and in histamine-mediated pruritus.


As a sedative when used as premedication and following general anesthesia, hydroxyzine may potentiate meperidine (Demerol®) and barbiturates, so their use in pre-anesthetic adjunctive therapy should be modified on an individual basis. Atropine and other belladonna alkaloids are not affected by the drug. Hydroxyzine is not known to interfere with the action of digitalis in any way and it may be used concurrently with this agent.


The effectiveness of hydroxyzine as an antianxiety agent for long term use, that is, more than 4 months, has not been assessed by systematic clinical studies. The physician should reassess periodically the usefulness of the drug for the individual patient.



Contraindications


Hydroxyzine, when administered to the pregnant mouse, rat and rabbit, induced fetal abnormalities in the rat and mouse at doses substantially above the human therapeutic range. Clinical data in human beings are inadequate to establish safety in early pregnancy. Until such data are available, hydroxyzine is contraindicated in early pregnancy.


Hydroxyzine Pamoate is contraindicated for patients who have shown a previous hypersensitivity to any component of this medication.



Warnings



Nursing Mothers


It is not known whether this drug is excreted in human milk. Since many drugs are so excreted, hydroxyzine should not be given to nursing mothers.



Precautions


THE POTENTIATING ACTION OF HYDROXYZINE MUST BE CONSIDERED WHEN THE DRUG IS USED IN CONJUNCTION WITH CENTRAL NERVOUS SYSTEM DEPRESSANTS SUCH AS NARCOTICS, NON-NARCOTIC ANALGESICS AND BARBITURATES. Therefore, when central nervous system depressants are administered concomitantly with hydroxyzine their dosage should be reduced.


Since drowsiness may occur with use of the drug, patients should be warned of this possibility and cautioned against driving a car or operating dangerous machinery while taking Hydroxyzine Pamoate capsules. Patients should be advised against the simultaneous use of other CNS depressant drugs and cautioned that the effect of alcohol may be increased.



Geriatric Use


A determination has not been made whether controlled clinical studies of Hydroxyzine Pamoate capsules included sufficient numbers of subjects aged 65 and over to define a difference in response from younger subjects. Other reported clinical experience has not identified differences in responses between the elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal or cardiac function and of concomitant disease or other drug therapy.


The extent of renal excretion of Hydroxyzine Pamoate capsules has not been determined. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selections.


Sedating drugs may cause confusion and over sedation in the elderly; elderly patients generally should be started on low doses of Hydroxyzine Pamoate capsules and observed closely.



Adverse Reactions


Side effects reported with the administration of Hydroxyzine Pamoate capsules are usually mild and transitory in nature.



Anticholinergic


Dry mouth.



Central Nervous System


Drowsiness is usually transitory and may disappear in a few days of continued therapy or upon reduction of the dose. Involuntary motor activity including rare instances of tremor and convulsions have been reported, usually with doses considerably higher than those recommended. Clinically significant respiratory depression has not been reported at recommended doses.


In post-marketing experience, the following additional undesirable effects have been reported:


Body as a Whole: allergic reaction


Nervous System: headache


Psychiatric: hallucination


Skin and Appendages: pruritus, rash, urticaria



Overdosage


The most common manifestation of overdosage of Hydroxyzine Pamoate capsules is hypersedation. Other reported signs and symptoms were convulsions, stupor, nausea and vomiting. As in the management of overdosage with any drug, it should be borne in mind that multiple agents may have been taken.


If vomiting has not occurred spontaneously, it should be induced. Immediate gastric lavage is also recommended. General supportive care, including frequent monitoring of the vital signs and close observation of the patient, is indicated. Hypotension, though unlikely, may be controlled with intravenous fluids and vasopressors.


Do not use epinephrine as hydroxyzine counteracts its pressor action. Caffeine and Sodium Benzoate Injection USP, may be used to counteract central nervous system depressant effects.


There is no specific antidote. It is doubtful that hemodialysis would be of any value in the treatment of overdosage with hydroxyzine. However, if other agents such as barbiturates have been ingested concomitantly, hemodialysis may be indicated. There is no practical method to quantitate hydroxyzine in body fluids or tissue after its ingestion or administration.



Hydroxyzine Pamoate Dosage and Administration


For symptomatic relief of anxiety and tension associated with psychoneurosis and as an adjunct in organic disease states in which anxiety is manifested: in adults, 50 mg to 100 mg q.i.d.; children under 6 years, 50 mg daily in divided doses; and over 6 years, 50 mg to 100 mg daily in divided doses.


For use in the management of pruritus due to allergic conditions such as chronic urticaria and atopic and contact dermatoses and in histamine-mediated pruritus: in adults: 25 mg t.i.d. or q.i.d.; children under 6 years, 50 mg daily in divided doses; and over 6 years, 50 mg to 100 mg daily in divided doses.


As a sedative when used as a premedication and following general anesthesia: 50 mg to 100 mg in adults and 0.6 mg/kg in children. When treatment is initiated by the intramuscular route of administration, subsequent doses may be administered orally.


As with all medications, the dosage should be adjusted according to the patient’s response to therapy.



How is Hydroxyzine Pamoate Supplied


Hydroxyzine Pamoate Capsules USP for oral administration are available as:


25 mg: (equivalent to 25 mg hydroxyzine hydrochloride) are light green/dark green capsules imprinted “E 613” and supplied as:


NDC 0185-0613-01 bottles of 100


NDC 0185-0613-05 bottles of 500


NDC 0185-0613-10 bottles of 1000


50 mg: (equivalent to 50 mg hydroxyzine hydrochloride) are dark green/white capsules imprinted “E 615” and supplied as:


NDC 0185-0615-01 bottles of 100


NDC 0185-0615-05 bottles of 500


NDC 0185-0615-10 bottles of 1000



Storage


Store at 20° to 25°C (68° to 77°F) [see USP Controlled Room Temperature]. Protect from moisture. Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure, as required.


To report SUSPECTED ADVERSE REACTIONS, contact Sandoz Inc. at 1-800-525-8747 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.


Manufactured for


Sandoz Inc.


Princeton, NJ 08540


Manufactured by


Epic Pharma, LLC


Laurelton, NY 11413


Rev. 09/09


MF0613REV09/09


OS7127


Sandoz Inc.


Princeton, NJ 08540


OS8905


Rev. 09/09



Hydroxyzine Pamoate Capsules USP, 25 mg x 100 Capsules


NDC 0185-0613-01


Hydroxyzine Pamoate Capsules USP


25 mg*


Rx only


100 Capsules


Sandoz




Hydroxyzine Pamoate Capsules USP, 50 mg x 100 Capsules


NDC 0185-0615-01


Hydroxyzine Pamoate Capsules USP


50 mg*


Rx only


100 Capsules


Sandoz










Hydroxyzine Pamoate 
Hydroxyzine Pamoate  capsule










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)0185-0613
Route of AdministrationORALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Hydroxyzine Pamoate (HYDROXYZINE)HYDROXYZINE HYDROCHLORIDE25 mg




























Inactive Ingredients
Ingredient NameStrength
COLLOIDAL SILICON DIOXIDE 
D&C YELLOW NO. 10 
FD&C GREEN NO. 3 
FD&C YELLOW NO. 6 
GELATIN 
HYDROXYPROPYL CELLULOSE 
LACTOSE MONOHYDRATE 
MAGNESIUM STEARATE 
PROPYLENE GLYCOL 
SODIUM LAURYL SULFATE 
SODIUM STARCH GLYCOLATE TYPE A POTATO 
TITANIUM DIOXIDE 


















Product Characteristics
ColorGREEN (light green/dark green)Scoreno score
ShapeCAPSULESize19mm
FlavorImprint CodeE613
Contains      


















Packaging
#NDCPackage DescriptionMultilevel Packaging
10185-0613-101000 CAPSULE In 1 BOTTLENone
20185-0613-05500 CAPSULE In 1 BOTTLENone
30185-0613-01100 CAPSULE In 1 BOTTLENone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA08747912/14/1981







Hydroxyzine Pamoate 
Hydroxyzine Pamoate  capsule










Product Information
Product TypeHUMAN PRESCRIPTION DRUGNDC Product Code (Source)0185-0615
Route of AdministrationORALDEA Schedule    








Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
Hydroxyzine Pamoate (HYDROXYZINE)HYDROXYZINE HYDROCHLORIDE50 mg




























Inactive Ingredients
Ingredient NameStrength
COLLOIDAL SILICON DIOXIDE 
D&C YELLOW NO. 10 
FD&C GREEN NO. 3 
FD&C YELLOW NO. 6 
GELATIN 
HYDROXYPROPYL CELLULOSE 
LACTOSE MONOHYDRATE 
MAGNESIUM STEARATE 
PROPYLENE GLYCOL 
SODIUM LAURYL SULFATE 
SODIUM STARCH GLYCOLATE TYPE A POTATO 
TITANIUM DIOXIDE 


















Product Characteristics
ColorGREEN (white)Scoreno score
ShapeCAPSULESize19mm
FlavorImprint CodeE615
Contains      


















Packaging
#NDCPackage DescriptionMultilevel Packaging
10185-0615-101000 CAPSULE In 1 BOTTLENone
20185-0615-05500 CAPSULE In 1 BOTTLENone
30185-0615-01100 CAPSULE In 1 BOTTLENone










Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
ANDAANDA08618312/14/1981


Labeler - Eon Labs, Inc. (012656273)
Revised: 09/2011Eon Labs, Inc.

More Hydroxyzine Pamoate resources


  • Hydroxyzine Pamoate Side Effects (in more detail)
  • Hydroxyzine Pamoate Dosage
  • Hydroxyzine Pamoate Use in Pregnancy & Breastfeeding
  • Drug Images
  • Hydroxyzine Pamoate Drug Interactions
  • Hydroxyzine Pamoate Support Group
  • 99 Reviews for Hydroxyzine Pamoate - Add your own review/rating


  • Hydroxyzine Pamoate Monograph (AHFS DI)

  • Atarax Consumer Overview

  • Atarax MedFacts Consumer Leaflet (Wolters Kluwer)

  • Hydroxyzine MedFacts Consumer Leaflet (Wolters Kluwer)

  • Hydroxyzine Professional Patient Advice (Wolters Kluwer)

  • Vistaril Consumer Overview



Compare Hydroxyzine Pamoate with other medications


  • Allergic Urticaria
  • Allergies
  • Anxiety
  • Interstitial Cystitis
  • Nausea/Vomiting
  • Pain
  • Pruritus
  • Sedation